<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35012575</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>10</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-021-00510-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Spinal cord motor neurons (MNs) from human iPS cells (iPSCs) have wide applications in disease modeling and therapeutic development for amyotrophic lateral sclerosis (ALS) and other MN-associated neurodegenerative diseases. We need highly efficient MN differentiation strategies for generating iPSC-derived disease models that closely recapitulate the genetic and phenotypic complexity of ALS. An important application of these models is to understand molecular mechanisms of action of FDA-approved ALS drugs that only show modest clinical efficacy. Novel mechanistic insights will help us design optimal therapeutic strategies together with predictive biomarkers to achieve better efficacy.</AbstractText><AbstractText Label="METHODS">We induce efficient MN differentiation from iPSCs in 4&#x2009;days using synthetic mRNAs coding two transcription factors (Ngn2 and Olig2) with phosphosite modification. These MNs after extensive characterization were applied in electrophysiological and neurotoxicity assays as well as transcriptomic analysis, to study the neuroprotective effect and molecular mechanisms of edaravone, an FDA-approved drug for ALS, for improving its clinical efficacy.</AbstractText><AbstractText Label="RESULTS">We generate highly pure and functional mRNA-induced MNs (miMNs) from control and ALS iPSCs, as well as embryonic stem cells. Edaravone alleviates H<sub>2</sub>O<sub>2</sub>-induced neurotoxicity and electrophysiological dysfunction in miMNs, demonstrating its neuroprotective effect that was also found in the glutamate-induced miMN neurotoxicity model. Guided by the transcriptomic analysis, we show a previously unrecognized effect of edaravone to induce the GDNF receptor RET and the GDNF/RET neurotrophic signaling in vitro and in vivo, suggesting a clinically translatable strategy to activate this key neuroprotective signaling. Notably, edaravone can replace required neurotrophic factors (BDNF and GDNF) to support long-term miMN survival and maturation, further supporting the neurotrophic function of edaravone-activated signaling. Furthermore, we show that edaravone and GDNF combined treatment more effectively protects miMNs from H<sub>2</sub>O<sub>2</sub>-induced neurotoxicity than single treatment, suggesting a potential combination strategy for ALS treatment.</AbstractText><AbstractText Label="CONCLUSIONS">This study provides methodology to facilitate iPSC differentiation and disease modeling. Our discoveries will facilitate the development of optimal edaravone-based therapies for ALS and potentially other neurodegenerative diseases.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, NHC, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hugo W. Moser Research Institute at Kennedy Krieger, 707 North Broadway, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hugo W. Moser Research Institute at Kennedy Krieger, 707 North Broadway, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yingchao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hugo W. Moser Research Institute at Kennedy Krieger, 707 North Broadway, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Xiping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Howard University, Washington, DC, 20059, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, NHC, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gui</LastName><ForeName>Gege</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weiqiang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richard</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taga</LastName><ForeName>Arens</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Pan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maragakis</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Mingyao</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6215-4959</Identifier><AffiliationInfo><Affiliation>Hugo W. Moser Research Institute at Kennedy Krieger, 707 North Broadway, Baltimore, MD, 21205, USA. ying@kennedykrieger.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. ying@kennedykrieger.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS099460</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051100">Glial Cell Line-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D051096">Proto-Oncogene Proteins c-ret</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C099282">RET protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>S798V6YJRP</RegistryNumber><NameOfSubstance UI="D000077553">Edaravone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077553" MajorTopicYN="N">Edaravone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051100" MajorTopicYN="N">Glial Cell Line-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051096" MajorTopicYN="N">Proto-Oncogene Proteins c-ret</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">MCI-186</Keyword><Keyword MajorTopicYN="N">Neurotrophic factor</Keyword><Keyword MajorTopicYN="N">Spinal cord motor neuron</Keyword><Keyword MajorTopicYN="N">Synthetic mRNA</Keyword><Keyword MajorTopicYN="N">Transcription factor</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35012575</ArticleId><ArticleId IdType="pmc">PMC8751314</ArticleId><ArticleId IdType="doi">10.1186/s13024-021-00510-y</ArticleId><ArticleId IdType="pii">10.1186/s13024-021-00510-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Qiang LFR, Abeliovich A. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders. Neuron. 2013;78(6):957&#x2013;969. doi: 10.1016/j.neuron.2013.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.06.002</ArticleId><ArticleId IdType="pubmed">23791192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito DOH, Suzuki N. Accelerating progress in induced pluripotent stem cell research for neurological diseases. Ann Neurol. 2012;72(2):167&#x2013;174. doi: 10.1002/ana.23596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23596</ArticleId><ArticleId IdType="pubmed">22926850</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung YWHE, Kim KY, et al. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Curr Opin Neurol. 2012;25(2):125&#x2013;130. doi: 10.1097/WCO.0b013e3283518226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e3283518226</ArticleId><ArticleId IdType="pmc">PMC3786112</ArticleId><ArticleId IdType="pubmed">22357218</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinchcliffe M, Smith A. Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degener Neurol Neuromuscul Dis. 2017;7:61&#x2013;70. doi: 10.2147/DNND.S135748.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S135748</ArticleId><ArticleId IdType="pmc">PMC6053101</ArticleId><ArticleId IdType="pubmed">30050378</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyotrophic Lateral Sclerosis/Riluzole Study Group II ea Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet. 1996;347(9013):1425&#x2013;1431. doi: 10.1016/S0140-6736(96)91680-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91680-3</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RGMJ, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS) motor neuron disease (MND) Cochrane Database Syst Rev. 2012;3:1&#x2013;34. doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Aoki M, et al. STe: safety and efcacy of edaravone in well defned patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16(7):505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull J. Reappraisal of an ALS trial: unaccounted procedural risk. Lancet Neurol. 2020;19(9):717&#x2013;718. doi: 10.1016/S1474-4422(20)30265-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30265-9</ArticleId><ArticleId IdType="pubmed">32822626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora JS. Edaravone for treatment of early-stage ALS. Lancet Neurol. 2017;16(10):772. doi: 10.1016/S1474-4422(17)30289-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30289-2</ArticleId><ArticleId IdType="pubmed">28920880</ArticleId></ArticleIdList></Reference><Reference><Citation>Akimoto M, Nakamura K. Writing group on behalf of the Edaravone ALSSG: Edaravone for treatment of early-stage ALS - Authors' reply. Lancet Neurol. 2017;16(10):772. doi: 10.1016/S1474-4422(17)30290-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30290-9</ArticleId><ArticleId IdType="pubmed">28920878</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei K, Watanabe K, Yuki S, Akimoto M, Sakata T, Palumbo J. Edaravone and its clinical development for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(sup1):5&#x2013;10. doi: 10.1080/21678421.2017.1353101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1353101</ArticleId><ArticleId IdType="pubmed">28872907</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD. Edaravone: a new drug approved for ALS. Cell. 2017;171(4):742. doi: 10.1016/j.cell.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, Come J, Piskorowski RA, Salah-Mohellibi N, Chevaleyre V, Peschanski M, Martinat C, Nedelec S. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol. 2015;33(1):89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Du ZW, Chen H, Liu H, Lu J, Qian K, Huang CL, Zhong X, Fan F, Zhang SC. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat Commun. 2015;6(1):6626. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuguchi R, Sugimori M, Takebayashi H, Kosako H, Nagao M, Yoshida S, Nabeshima Y, Shimamura K, Nakafuku M. Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons. Neuron. 2001;31(5):757&#x2013;771. doi: 10.1016/S0896-6273(01)00413-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00413-5</ArticleId><ArticleId IdType="pubmed">11567615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni EO, Mahony S, Closser M, Morrison CA, Nedelec S, Williams DJ, An D, Gifford DK, Wichterle H. Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity. Nat Neurosci. 2013;16(9):1219&#x2013;1227. doi: 10.1038/nn.3467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3467</ArticleId><ArticleId IdType="pmc">PMC3820498</ArticleId><ArticleId IdType="pubmed">23872598</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y, Zhan X, Sun S, Karuppagounder SS, Xia S, Dawson VL, Dawson TM, Laterra J, Zhang J, Ying M. Synthetic mRNAs drive highly efficient iPS cell differentiation to dopaminergic neurons. Stem Cells Transl Med. 2019;8(2):112&#x2013;123. doi: 10.1002/sctm.18-0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.18-0036</ArticleId><ArticleId IdType="pmc">PMC6344911</ArticleId><ArticleId IdType="pubmed">30387318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagal J, Zhan X, Xu J, Tilghman J, Karuppagounder SS, Chen L, Dawson VL, Dawson TM, Laterra J, Ying M. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Transl Med. 2014;3(8):888&#x2013;898. doi: 10.5966/sctm.2013-0213.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2013-0213</ArticleId><ArticleId IdType="pmc">PMC4116248</ArticleId><ArticleId IdType="pubmed">24904172</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippis L, Lamorte G, Snyder EY, Malgaroli A, Vescovi AL. A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells. 2007;25(9):2312&#x2013;2321. doi: 10.1634/stemcells.2007-0040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/stemcells.2007-0040</ArticleId><ArticleId IdType="pubmed">17556596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907&#x2013;915. doi: 10.1038/s41587-019-0201-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0201-4</ArticleId><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290&#x2013;295. doi: 10.1038/nbt.3122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3122</ArticleId><ArticleId IdType="pmc">PMC4643835</ArticleId><ArticleId IdType="pubmed">25690850</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25. doi: 10.1186/gb-2010-11-3-r25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2010-11-3-r25</ArticleId><ArticleId IdType="pmc">PMC2864565</ArticleId><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y, Nomura E, Shang J, Feng T, Huang Y, Liu X, Shi X, Nakano Y, Hishikawa N, Sato K, Takemoto M, Yamashita T, Abe K. Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis. J Neurosci Res. 2019;97(5):607&#x2013;619. doi: 10.1002/jnr.24368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24368</ArticleId><ArticleId IdType="pubmed">30565312</ArticleId></ArticleIdList></Reference><Reference><Citation>Richner M, Jager SB, Siupka P, Vaegter CB. Hydraulic extrusion of the spinal cord and isolation of dorsal root ganglia in rodents. J Vis Exp. 2017. 10.3791/55226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5352284</ArticleId><ArticleId IdType="pubmed">28190031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanabe YRH, Jessell TM. Induction of motor neurons by sonic hedgehog is independent of floor plate differentiation. Curr Biol. 1995;5(6):651&#x2013;658. doi: 10.1016/S0960-9822(95)00130-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(95)00130-8</ArticleId><ArticleId IdType="pubmed">7552176</ArticleId></ArticleIdList></Reference><Reference><Citation>Roelink TQCH. The notch response inhibitor DAPT enhances neuronal differentiation in embryonic stem cell-derived embryoid bodies independently of sonic hedgehog signaling. Dev Dyn. 2007;236(3):886&#x2013;892. doi: 10.1002/dvdy.21083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.21083</ArticleId><ArticleId IdType="pubmed">17295317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, Xu W, Yang N, Danko T, Chen L, Wernig M, S&#xfc;dhof TC. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78(5):785&#x2013;798. doi: 10.1016/j.neuron.2013.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.05.029</ArticleId><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ward ME, Chen R, Liu K, Tracy TE, Chen X, Xie M, Sohn PD, Ludwig C, Meyer-Franke A, Karch CM, Ding S, Gan L. Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening. Stem Cell Reports. 2017;9(4):1221&#x2013;1233. doi: 10.1016/j.stemcr.2017.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.08.019</ArticleId><ArticleId IdType="pmc">PMC5639430</ArticleId><ArticleId IdType="pubmed">28966121</ArticleId></ArticleIdList></Reference><Reference><Citation>Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 1996;379(6562):257&#x2013;262. doi: 10.1038/379257a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/379257a0</ArticleId><ArticleId IdType="pubmed">8538791</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodakhah K, Melishchuk A, Armstrong CM. Killing K channels with TEA+ Proc Natl Acad Sci U S A. 1997;94(24):13335&#x2013;13338. doi: 10.1073/pnas.94.24.13335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.24.13335</ArticleId><ArticleId IdType="pmc">PMC24309</ArticleId><ArticleId IdType="pubmed">9371846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S, Bruijn LI, Chandran S, Eggan K, Ho R, Klim JR, Livesey MR, Lowry E, Macklis JD, Rushton D, Sadegh C, Sareen D, Wichterle H, Zhang SC, Svendsen CN. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat Neurosci. 2016;19(4):542&#x2013;553. doi: 10.1038/nn.4273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4273</ArticleId><ArticleId IdType="pmc">PMC5015775</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MA, Weick JP, Pearce RA, Zhang SC. Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci. 2007;27(12):3069&#x2013;3077. doi: 10.1523/JNEUROSCI.4562-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4562-06.2007</ArticleId><ArticleId IdType="pmc">PMC2735200</ArticleId><ArticleId IdType="pubmed">17376968</ArticleId></ArticleIdList></Reference><Reference><Citation>Takazawa T, Croft GF, Amoroso MW, Studer L, Wichterle H, Macdermott AB. Maturation of spinal motor neurons derived from human embryonic stem cells. PLoS One. 2012;7(7):e40154. doi: 10.1371/journal.pone.0040154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0040154</ArticleId><ArticleId IdType="pmc">PMC3388990</ArticleId><ArticleId IdType="pubmed">22802953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SS, Sandoe J, Perez NP, Williams LA, Lee S, Boulting G, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7(1):1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Orco M, Milani P, Cereda C. Hydrogen peroxide-mediated induction of SOD1 gene transcription is independent from Nrf2 in a cellular model of neurodegeneration. Biochim Biophys Acta. 1859;2015(2):315&#x2013;323. doi: 10.1016/j.bbagrm.2015.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2015.11.009</ArticleId><ArticleId IdType="pubmed">26619801</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayon T, Stamataki D, Perez-Carrasco R, Garcia-Perez L, Barrington C, Melchionda M, et al. Species-specific pace of development is associated with differences in protein stability. Science. 2020;369(6510). 10.1126/science.aba7667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116327</ArticleId><ArticleId IdType="pubmed">32943498</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammen PP, Shelton JM, Ye Q, Kanatous SB, McGrath AJ, Richardson JA, Garry DJ. Cytoglobin is a stress-responsive hemoprotein expressed in the developing and adult brain. J Histochem Cytochem. 2006;54(12):1349&#x2013;1361. doi: 10.1369/jhc.6A7008.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/jhc.6A7008.2006</ArticleId><ArticleId IdType="pmc">PMC3958125</ArticleId><ArticleId IdType="pubmed">16899760</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Garcia-Barcelo MM, Tam PK, Lui VC. HOXB5 cooperates with NKX2-1 in the transcription of human RET. PLoS One. 2011;6(6):e20815. doi: 10.1371/journal.pone.0020815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020815</ArticleId><ArticleId IdType="pmc">PMC3108997</ArticleId><ArticleId IdType="pubmed">21677782</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon TY, Ngan ES, Poon HC, So MT, Lui VC, Tam PK, Garcia-Barcelo MM. Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3. J Pediatr Surg. 2009;44(10):1904&#x2013;1912. doi: 10.1016/j.jpedsurg.2008.11.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2008.11.055</ArticleId><ArticleId IdType="pubmed">19853745</ArticleId></ArticleIdList></Reference><Reference><Citation>Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci. 2002;3(5):383&#x2013;394. doi: 10.1038/nrn812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn812</ArticleId><ArticleId IdType="pubmed">11988777</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618&#x2013;630. doi: 10.1016/j.stem.2010.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2010.08.012</ArticleId><ArticleId IdType="pmc">PMC3656821</ArticleId><ArticleId IdType="pubmed">20888316</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlaeger TM, Daheron L, Brickler TR, Entwisle S, Chan K, Cianci A, DeVine A, Ettenger A, Fitzgerald K, Godfrey M, Gupta D, McPherson J, Malwadkar P, Gupta M, Bell B, Doi A, Jung N, Li X, Lynes MS, Brookes E, Cherry ABC, Demirbas D, Tsankov AM, Zon LI, Rubin LL, Feinberg AP, Meissner A, Cowan CA, Daley GQ. A comparison of non-integrating reprogramming methods. Nat Biotechnol. 2015;33(1):58&#x2013;63. doi: 10.1038/nbt.3070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3070</ArticleId><ArticleId IdType="pmc">PMC4329913</ArticleId><ArticleId IdType="pubmed">25437882</ArticleId></ArticleIdList></Reference><Reference><Citation>Poleganov MA, Eminli S, Beissert T, Herz S, Moon JI, Goldmann J, Beyer A, Heck R, Burkhart I, Barea Roldan D, T&#xfc;reci &#xd6;, Yi K, Hamilton B, Sahin U. Efficient reprogramming of human fibroblasts and blood-derived endothelial progenitor cells using nonmodified RNA for reprogramming and immune evasion. Hum Gene Ther. 2015;26(11):751&#x2013;766. doi: 10.1089/hum.2015.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2015.045</ArticleId><ArticleId IdType="pubmed">26381596</ArticleId></ArticleIdList></Reference><Reference><Citation>Goparaju SK, Kohda K, Ibata K, Soma A, Nakatake Y, Akiyama T, Wakabayashi S, Matsushita M, Sakota M, Kimura H, Yuzaki M, Ko SBH, Ko MSH. Rapid differentiation of human pluripotent stem cells into functional neurons by mRNAs encoding transcription factors. Sci Rep. 2017;7(1):42367. doi: 10.1038/srep42367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42367</ArticleId><ArticleId IdType="pmc">PMC5304326</ArticleId><ArticleId IdType="pubmed">28205555</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S, Brambilla L, Kienlen-Campard P. A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology. Front Neurol. 2018;9:384. doi: 10.3389/fneur.2018.00384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00384</ArticleId><ArticleId IdType="pmc">PMC5988896</ArticleId><ArticleId IdType="pubmed">29899726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LJ, Lu YY, Nakano I. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci. 2002;22(16):6920&#x2013;6928. doi: 10.1523/JNEUROSCI.22-16-06920.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-16-06920.2002</ArticleId><ArticleId IdType="pmc">PMC6757879</ArticleId><ArticleId IdType="pubmed">12177190</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM, Avalos P, Ma AA, Alkaslasi M, Cho N, Wyss L, Vit JP, Godoy M, Suezaki P, Shelest O, Bankiewicz KS, Svendsen CN. Transplantation of neural progenitor cells expressing glial cell line-derived neurotrophic factor into the motor cortex as a strategy to treat amyotrophic lateral sclerosis. Stem Cells. 2018;36(7):1122&#x2013;1131. doi: 10.1002/stem.2825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2825</ArticleId><ArticleId IdType="pubmed">29656478</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Lange DJ, Ho L, Bonini S, Shao B, Salton SR, Thomas S, Pasinetti GM. Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis. Int J Med Sci. 2008;5:92&#x2013;99. doi: 10.7150/ijms.5.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.5.92</ArticleId><ArticleId IdType="pmc">PMC2323610</ArticleId><ArticleId IdType="pubmed">18432310</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y, Motoyama S, Nakamura S, Shimazawa M, Hara H. Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis. Neurochem Res. 2019;44(4):897&#x2013;904. doi: 10.1007/s11064-019-02725-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-019-02725-4</ArticleId><ArticleId IdType="pubmed">30656593</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimazawa M, Tanaka H, Hara H, et al. An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS. PLoS One. 2010;5(12):e15307. doi: 10.1371/journal.pone.0015307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015307</ArticleId><ArticleId IdType="pmc">PMC3000345</ArticleId><ArticleId IdType="pubmed">21151573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandolesi G, Gargano S, Pennuto M, Illi B, Molfetta R, Soucek L, Mosca L, Levi A, Jucker R, Nasi S. NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction. FEBS Lett. 2002;510(1-2):50&#x2013;56. doi: 10.1016/S0014-5793(01)03227-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(01)03227-6</ArticleId><ArticleId IdType="pubmed">11755530</ArticleId></ArticleIdList></Reference><Reference><Citation>Alder J, Thakker-Varia S, Bangasser DA, Kuroiwa M, Plummer MR, Shors TJ, Black IB. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J Neurosci. 2003;23(34):10800&#x2013;10808. doi: 10.1523/JNEUROSCI.23-34-10800.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-34-10800.2003</ArticleId><ArticleId IdType="pmc">PMC3374594</ArticleId><ArticleId IdType="pubmed">14645472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerchia L, D'Alessio A, Amabile G, Duconge F, Pestourie C, Tavitian B, Libri D, de Franciscis V. An autocrine loop involving ret and glial cell-derived neurotrophic factor mediates retinoic acid-induced neuroblastoma cell differentiation. Mol Cancer Res. 2006;4(7):481&#x2013;488. doi: 10.1158/1541-7786.MCR-06-0050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-06-0050</ArticleId><ArticleId IdType="pubmed">16849523</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocco C, Corda G, Lisci C, Noli B, Carta M, Brancia C, Manca E, Masala C, Marrosu F, Solla P, Manconi B, Bongioanni P, Ferri GL. VGF peptides as novel biomarkers in Parkinson's disease. Cell Tissue Res. 2020;379(1):93&#x2013;107. doi: 10.1007/s00441-019-03128-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-019-03128-1</ArticleId><ArticleId IdType="pubmed">31713727</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh PN, Meldrum BS. Excitotoxicity in ALS. Neurology. 1996;47(Issue 6, Supplement 4):S221&#x2013;S227. doi: 10.1212/WNL.47.6_Suppl_4.221S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.6_Suppl_4.221S</ArticleId><ArticleId IdType="pubmed">8959993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>